Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2003
05/21/2003EP1192450A4 High energy phototherapeutic agents
05/21/2003EP1146912A4 Method for improved radiation therapy
05/21/2003EP1144003A4 Methods and devices for delivery of agents to breast milk ducts
05/21/2003EP1142578B1 Method for producing an antitumoral agent and antitumoral agent thus obtained
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003EP1023268B1 Isoquinolines as urokinase inhibitors
05/21/2003EP0915895B1 New salts of anionic complexes of ru(iii), as antimetastatic and antineoplastic agents
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0851855B9 Acylated derivatives of melatonin and its analogues, useful as medicaments
05/21/2003EP0792148B1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/21/2003CN1419598A Detection of immunological memory, T-cell conjugates for pathology imaging and therapy
05/21/2003CN1419597A Simultaneous stimulation and concentration of cells
05/21/2003CN1419588A A natural fluorescent dye obtained from a marine invertebrate, compositions from a marine invertebrate, compositions containing the said dye and their use
05/21/2003CN1419565A Chimeric Prostate-homing peptides with pro-apoptotic activity
05/21/2003CN1419559A Tricyclic protein kinase inhibitors
05/21/2003CN1419558A Process for producing camptothecin
05/21/2003CN1419553A Prodigiosin-derivatives as neoplastic and anti-viral agents
05/21/2003CN1419552A 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors
05/21/2003CN1419548A 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419455A Physiologically active compositions of basidiomycotina and araliaceae extracts
05/21/2003CN1419452A Synergistic methods and compositions for treating cancer
05/21/2003CN1418680A Medicine composition for treating uterus tumour
05/21/2003CN1418663A Method for appliation of paederia schandens for treating leukemia and other difficult and complicated cases
05/21/2003CN1418639A Bc 1-2 gene antisense nucleotide prepn. used for treating nasopharyngeal carcinoma, and its application
05/21/2003CN1418633A Anti-cancer assistant medicine contg. 20(S)-protopanaxadiol as effective component, and its application
05/21/2003CN1418622A Demethyl catharidine lipid for treating malignant tumour, and its prepn. method
05/21/2003CN1109103C Artificial culture of jiuzhou caterpillar fungus and the application of its sporophore
05/21/2003CN1109046C Induction of cytotoxic T-lymphocyte responses
05/21/2003CN1109041C Process for preparing substituted disulfide derivative and targeted form thereof
05/21/2003CN1109034C Composition of gambogic acid compounds with anticancer activity and its preparing process
05/21/2003CN1109031C Bicycle-aromatic compound
05/21/2003CN1109026C Sidechain-beering taxanes like compounds
05/21/2003CN1108826C Pharmaceutical kit with 1-hydroxy ethylidene diphosphonate and its preparation and use
05/21/2003CN1108796C Use of anticancer material and production method of said anti-cancer material
05/21/2003CN1108792C External-use medicine composition for treating angioma and preparation method thereof
05/20/2003US6566553 Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline
05/20/2003US6566517 Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
05/20/2003US6566514 Antisense oligonucleotides for use in the treatment of tumors
05/20/2003US6566506 Useful in extending the in vivo circulating life of biologically active materials
05/20/2003US6566498 Proteins for use in the treatment of thrombosis and tumor metastisis
05/20/2003US6566491 Cyclopeptide derivatives
05/20/2003US6566385 And the prenylation of the oncogene protein Ras; peptidomimetic macrocyclic compounds
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566366 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
05/20/2003US6566363 5-amino-3-substituted-pyrazolo(4,5-d)thiazole compounds that mediate and/or inhibit the activity of cyclin-dependent kinases, useful for treating cancer, angiogenesis and cellular proliferation
05/20/2003US6566358 Cyclocarbamate derivatives as progesterone receptor modulators
05/20/2003US6566353 Method of treating malignancy associated hypercalcemia using active vitamin D analogues
05/20/2003US6566352 Administering alpha -hydroxy-2-methylene-19-nor-pregnacalciferol compound for therapy of psoriasis
05/20/2003US6566338 Administering caspase inhibitor for therapy of oral mucositis, gastrointestinal mucositis, bladder mucositis or proctitis resulting from chemotherapy or radiation therapy of cancer in an animal
05/20/2003US6566336 Compounds alkylating specific base sequence of DNA and method for synthesizing the same
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
05/20/2003US6566080 Assay for and uses of peptide hormone receptor agonists
05/20/2003US6566078 36P6D5: secreted tumor antigen
05/20/2003US6566063 Diagnosing cancer in cells; obtain cells, monitor expression of gland-specific transcription factor, compare to control, evaluate for cancer
05/20/2003US6565897 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
05/20/2003US6565874 Polymeric delivery formulations of leuprolide with improved efficacy
05/20/2003US6565870 In situ administering neurotoxin
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565852 Tumor antigen; vaccine; antitumor, anticarcinogenic agents
05/20/2003US6565845 Introducing a viral expression vector having a tumoricidal or susceptibility gene into a mammalian cell and attaching the cell to a support matrix in vitro; transferring the supported cells to mammalian tumor cells; durability; brains
05/20/2003US6565831 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/20/2003US6565828 Bifunctional chelant for attaching diagnostic metals and therpeutic isotopes to target specific biomolecules; heavy metal detoxification
05/20/2003CA2322944C Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
05/20/2003CA2289219C 1-substituted, 2-substituted 1h-imidazo[4,5-c]quinolin-4-amines
05/20/2003CA2262001C Mhc binding peptide oligomers and methods of use
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers
05/20/2003CA2102302C Recombinant defective adenoviruses expressing cytokines for an antitumoral treatment
05/15/2003WO2003040725A2 Method of determining whether a patient afflicted with cancer can be treated by a therapeutic agent that targets the 17-1a antigen
05/15/2003WO2003040693A2 Peptides that home to tumor lymphatic vasculature and methods of using same
05/15/2003WO2003040399A2 Therapeutic methods for nucleic acid delivery vehicles
05/15/2003WO2003040375A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040369A2 Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines
05/15/2003WO2003040366A2 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003WO2003040365A2 Pna-conjugate or pna-conjugate mixture for treating diseases related to the human papillomavirus
05/15/2003WO2003040358A1 Somatic cell derived embryonic stem cells and its differentiated cells
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040317A2 Lung cancer therapeutics and diagnostics
05/15/2003WO2003040313A2 Il-21 antagonists
05/15/2003WO2003040296A2 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003040294A2 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs
05/15/2003WO2003040188A1 Antibody stimulating il-1ra production
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003040164A2 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003WO2003040144A2 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
05/15/2003WO2003040143A1 Amine salts of an integrin receptor antagonist
05/15/2003WO2003040141A1 Oxazolyl-phenyl-2,4-diamino-pyrimidine compounds and methods for treating hyperproliferative disorders
05/15/2003WO2003040134A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
05/15/2003WO2003040131A1 Aminopyrimidines and pyridines
05/15/2003WO2003040125A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003WO2003040119A1 Angiogenesis inhibitors
05/15/2003WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003WO2003040110A1 Triazole derivatives as cyclooxygenase (cox) inhibitors
05/15/2003WO2003040109A2 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040108A1 Quinazoline derivatives as antitumor agents
1 ... 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 ... 2211